VAERS Explorer
Back to explore

Report #2827329

Received Feb 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
NY
Recovered
Unknown
Vaccinated
Apr 1, 2023
Onset
—
Days to onset
—
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNK——
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNK——

Symptoms (2)

Incomplete course of vaccinationNo adverse event

Symptom narrative

has not yet received their third dose; No additional AE; This spontaneous report was received from a Pharmacist and refers to a 25-year-old male patient. The patient's medical, concurrent conditions, previous drugs reactions or allergies and concomitant therapies were not reported. On an unknown date in April 2023, the patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), (Dose 1) (strength, dose description, route of administration, lot # and expiration date were not reported). On an unknown date in June 2023, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) (GARDASIL®9), (dose 2) (strength, dose description, route of administration, lot # and expiration date were not reported) as prophylaxis, however, the patient has not yet received their third dose (Inappropriate schedule of product administration). No symptoms reported, No additional adverse event.